about
Molecular biology of lung cancerOncogenes: The Passport for Viral Oncolysis Through PKR InhibitionRole of Exosomal Noncoding RNAs in Lung CarcinogenesisThe Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung CancerTumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectivesSingle nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancerEvaluation of the use of therapeutic peptides for cancer treatmentSLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic markerPopulation effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients.Prognostic factors in resected lung carcinomas.Involvement of p53 mutation and mismatch repair proteins dysregulation in NNK-induced malignant transformation of human bronchial epithelial cellsEGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.Biomarkers in early-stage non-small-cell lung cancer: current concepts and future directions.Mutations of epigenetic regulatory genes are common in thymic carcinomasPICT1 expression is a poor prognostic factor in non-small cell lung cancer.A novel differential diagnostic model for multiple primary lung cancer: Differentially-expressed gene analysis of multiple primary lung cancer and intrapulmonary metastasisExpansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model.Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma.Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stromaImpact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation.Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly.An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K SignalingTP53 transcription factor for the NEDD9/HEF1/Cas-L gene: potential targets in Non-Small Cell Lung Cancer treatment.Identification of Genetic Mutations in Human Lung Cancer by Targeted Sequencing.Mer receptor tyrosine kinase is frequently overexpressed in human non-small cell lung cancer, confirming resistance to erlotinib.Radiation/paclitaxel treatment of p53-abnormal non-small cell lung cancer xenograft tumor and associated mechanism.Leveraging protein quaternary structure to identify oncogenic driver mutations.Genetic and biochemical alterations in non-small cell lung cancer.Utilisation of nanoparticle technology in cancer chemoresistance.Genotyping of Human Papillomavirus and TP53 Mutaions at Exons 5 to 7 in Lung Cancer Patients from Iran.Modification of tumor cell exosome content by transfection with wt-p53 and microRNA-125b expressing plasmid DNA and its effect on macrophage polarization.A negative regulation loop of long noncoding RNA HOTAIR and p53 in non-small-cell lung cancer.Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology.Correlation of neuroendocrine features with prognosis of non-small cell lung cancerRole of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer.Epigenetic therapy potential of suberoylanilide hydroxamic acid on invasive human non-small cell lung cancer cellsThe potential of exploiting DNA-repair defects for optimizing lung cancer treatment.New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy.Advances in adenovirus-mediated p53 cancer gene therapy.Standardized decision support in next generation sequencing reports of somatic cancer variants.
P2860
Q24606677-9B2F8E6C-4D32-4B52-92E9-4B2020C7FEE2Q26739777-D2FEA76D-134D-4EB3-AE24-9449979B1683Q27000282-E4E8B76C-B82E-4D41-A971-73FC29CCBF2FQ27012447-7D98D79E-FD61-4C75-944F-9499829FAC2FQ27014117-6CEEF0C5-7B49-4019-B4D8-9E5B03F939D9Q28816916-5B183521-3589-4305-9B67-D739089B97AEQ29048586-C71124BD-539C-47E7-8B02-1678D9EFB646Q33576879-02BF6D0D-F844-435F-8A95-FD3A94998299Q33584831-5AE4D9DB-D53D-4A4F-B621-7712F8CE5F69Q33697964-39B2214D-D405-4B35-B228-A62EB742D1A9Q34120722-05D35017-75E2-4684-9364-95D9CC156854Q34421001-B9108685-4727-4EE1-A71C-13CAF343BD8BQ34623884-295FF377-62EE-48C9-B063-E09B746DD48CQ34648225-8F7F4015-2A8C-4A87-AB93-55A4EB761BA4Q34781290-A2D334DE-9186-430A-818F-7E52AAC18003Q35042319-C0AD95DF-5DFB-431F-9221-28C736992332Q35068046-ED0AFA37-0CDB-4579-B43B-1F54DFC11147Q35076075-A66010E4-B10D-4502-9FBE-D1364FB05439Q35183870-E9ADCC11-7582-4422-9CDD-32B93078A1D0Q35290403-0CB8A9FF-6577-40D5-9C3E-C45E94B93DFDQ35593081-88E62D6D-0C7E-4FBF-8541-D1DC919B5E94Q35593321-282E43EA-580A-43A7-93E5-B01F9ACDF78DQ35646576-D101842D-E89B-44AA-8664-239C5862EACDQ35811159-4C75A2F3-7FA8-495B-9A06-5645239AE3F7Q35832327-B046B4F3-BEDC-4FD4-B46B-F5A1970B0F75Q35964863-3DDCCE19-E2AE-4DD5-8DAD-006242C1000FQ35965565-910CD1F2-2E79-4E96-832B-E0C8BEE23254Q36184584-35B0FFCE-7A65-4E52-91E1-FB7C4D33D97CQ36421258-0746F75E-FE4E-4ADA-920D-555BC6D6F03BQ37207075-BB5E7F2A-FA18-40A3-A852-0DEF6E30160FQ37224277-3B308260-A310-404D-B649-F3879C446FC5Q37276552-969A4D12-B424-4C1A-9B98-AB973D1E05AAQ37580410-B1DDBF8A-FEFF-4814-A862-BE488863CB51Q37687692-83594A5E-83A7-446D-93D2-96D96A1FFD13Q37690890-0441CF57-115C-43D7-9D4A-400568B6D9A1Q37708851-E9391E6D-D8B6-4C87-95A8-E17716596DE1Q37983690-399616F3-644D-4990-9B75-D623283C59FDQ38036571-1FB99F91-6C63-4959-AC7B-FB4A8782E105Q38150910-86A20D6C-FF72-4977-A61C-AEA85CDA372DQ38207312-32F86FB8-5E0B-4ABA-804C-8511C1F766A4
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
TP53 mutations in nonsmall cell lung cancer
@ast
TP53 mutations in nonsmall cell lung cancer
@en
TP53 mutations in nonsmall cell lung cancer
@nl
type
label
TP53 mutations in nonsmall cell lung cancer
@ast
TP53 mutations in nonsmall cell lung cancer
@en
TP53 mutations in nonsmall cell lung cancer
@nl
prefLabel
TP53 mutations in nonsmall cell lung cancer
@ast
TP53 mutations in nonsmall cell lung cancer
@en
TP53 mutations in nonsmall cell lung cancer
@nl
P2860
P921
P356
P1476
TP53 mutations in nonsmall cell lung cancer
@en
P2093
Akira Mogi
Hiroyuki Kuwano
P2860
P304
P356
10.1155/2011/583929
P577
2011-01-18T00:00:00Z